Acid Ceramidase Inhibitors: A De Novo Drug Target and a New Class of Drug for Glioblastoma Glioblastoma remains the most common malignant cancer of the central nervous system with an overall survival <1.5 years. Therapeutically resistant glioblastoma or glioblastoma stem-like... Read More
Photocatalysis is the process where the rate of a photoreaction is altered by the presence of a substance that is not itself consumed in the reaction. Photocatalysis can be heterogeneous or homogeneous, with the majority of the research up-to-date focused... Read More
“Determining the impact of protein-protein interactions on Transglutaminase 2 activity” Tonya N. Zeczycki, PhD Assistant Professor Department of Biochemistry and Molecular Biology and the East Carolina Diabetes and Obesity Institute East Carolina Heart Institute Host: Nicholas R. Silvaggi ABSTRACT In... Read More